Cargando…
Recombinant human activated protein C for the treatment of severe sepsis and septic shock: a study protocol for incorporating observational evidence using a Bayesian approach
INTRODUCTION: Activated protein C (aPC) plays a pivotal role in modulating a severe inflammatory response and is thought to be beneficial for patients with sepsis. However, several meta-analyses of randomised controlled trials (RCTs) show that aPC is not significantly associated with improved surviv...
Autor principal: | Zhang, Zhongheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120342/ https://www.ncbi.nlm.nih.gov/pubmed/25082420 http://dx.doi.org/10.1136/bmjopen-2014-005622 |
Ejemplares similares
-
The efficacy of activated protein C for the treatment of sepsis: incorporating observational evidence with a Bayesian approach
por: Zhang, Zhongheng
Publicado: (2015) -
Fluids in Sepsis and Septic Shock (FISSH): protocol for a pilot randomised controlled trial
por: Rochwerg, Bram, et al.
Publicado: (2017) -
Effects of evidence-based ICU care on long-term outcomes of patients with sepsis or septic shock (ILOSS): protocol for a multicentre prospective observational cohort study in Japan
por: Liu, Keibun, et al.
Publicado: (2022) -
Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials
por: Chang, Wei, et al.
Publicado: (2018) -
Vitamin C therapy for patients with sepsis or septic shock: a protocol for a systematic review and a network meta-analysis
por: Fujii, Tomoko, et al.
Publicado: (2019)